Insight Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Insight Advisors's LLY Position: Q1 2026 in Review
Insight Advisors increased its Eli Lilly (LLY) stake by 0.07% in Q1 2026, buying an estimated $1.01K and bringing the position to 1,525 shares worth $1.4M. The position accounts for 0.27% of the portfolio, ranked #52.
Insight Advisors first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.64M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Insight Advisors held 1,525 shares of Eli Lilly worth $1.4M as of Q1 2026.
- Insight Advisors bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
- Eli Lilly made up 0.27% of Insight Advisors's portfolio in Q1 2026, its #52 holding.
- Insight Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- Insight Advisors's Eli Lilly position peaked at $1.64M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Insight Advisors's 13F filing for Q1 2026, filed 12 May 2026.